Dr Ryuichi Sakate, research leader of the Laboratory of Rare Disease Resource Library, and Dr Tomonori Kimura, director of the Center for Rare Disease Research, repoted the recent trend of drug repositioning in rare and intractable diseases. This report was published in Drug Discovery Today.
You can find the details here.